BOONE CAPITAL MANAGEMENT LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1882053
ATLANTA, GA
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,889,945
New position
Shares Held
615,287
first reported quarter
Ownership
0.721%
of shares outstanding
% of Portfolio
3.48%
of 13F equity value
Holder Rank
#34
of 193 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOONE CAPITAL MANAGEMENT LLC holds $221,198,549 across 10 Biotechnology names. GLUE ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
415,641 | $48,659,091 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
519,977 | $41,228,976 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
583,219 | $33,371,791 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
339,720 | $25,302,345 | |
| 5 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
615,287 | $14,889,945 | |
| 6 | KOD |
Kodiak Sciences Inc.
|
378,010 | $14,727,269 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
455,605 | $14,242,212 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
113,173 | $12,977,547 |
All Filings in GLUE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,889,945 | 615,287 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||